VI
WST icon

Vestcor Inc’s West Pharmaceutical WST Stock Holding History

Vestcor Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$575K Hold
1,603
– – 0.01% 727
2026
Q1 		$402K Hold
1,603
– – 0.01% 809
2025
Q4 		$441K Hold
1,603
– – 0.01% 740
2025
Q3 		$421K Hold
1,603
– – 0.01% 770
2025
Q2 		$351K Sell
1,603
-12
-0.7% -$2.56K 0.01% 816
2025
Q1 		$362K Buy
1,615
+427
+36% +$118K 0.01% 786
2024
Q4 		$389K Sell
1,188
-329
-22% -$104K 0.01% 772
2024
Q3 		$455K Hold
1,517
– – 0.01% 735
2024
Q2 		$500K Hold
1,517
– – 0.02% 662
2024
Q1 		$600K Sell
1,517
-13
-0.8% -$4.81K 0.02% 592
2023
Q4 		$539K Sell
1,530
-21
-1% -$7.43K 0.02% 636
2023
Q3 		$582K Sell
1,551
-194
-11% -$75K 0.02% 572
2023
Q2 		$667K Sell
1,745
-940
-35% -$336K 0.02% 536
2023
Q1 		$930K Sell
2,685
-11,971
-82% -$3.5M 0.03% 471
2022
Q4 		$3.45M Sell
14,656
-2,622
-15% -$621K 0.13% 183
2022
Q3 		$4.25M Buy
17,278
+115
+0.7% +$35K 0.16% 140
2022
Q2 		$5.19M Sell
17,163
-17,305
-50% -$5.63M 0.19% 113
2022
Q1 		$14.2M Sell
34,468
-28,252
-45% -$11.1M 0.49% 43
2021
Q4 		$29.4M Sell
62,720
-2,016
-3% -$868K 1.04% 11
2021
Q3 		$27.5M Buy
64,736
+21,517
+50% +$9.07M 0.99% 9
2021
Q2 		$15.5M Buy
43,219
+40,361
+1,412% +$13.3M 0.52% 43
2021
Q1 		$805K Sell
2,858
-1,149
-29% -$329K 0.03% 520
2020
Q4 		$1.14M Buy
4,007
+1,626
+68% +$456K 0.05% 388
2020
Q3 		$655K Sell
2,381
-47
-2% -$12.4K 0.03% 449
2020
Q2 		$552K Buy
2,428
+1,078
+80% +$212K 0.03% 404
2020
Q1 		$206K Sell
1,350
-140
-9% -$21.5K 0.01% 613
2019
Q4 		$224K Buy
+1,490
New +$217K 0.01% 677

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vestcor Inc's WST Position: Q2 2026 in Review

Vestcor Inc held its West Pharmaceutical (WST) position steady in Q2 2026 at 1,603 shares worth $575K. The position accounts for 0.01% of the portfolio, ranked #727.

Vestcor Inc first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $29.4M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Vestcor Inc held 1,603 shares of West Pharmaceutical worth $575K as of Q2 2026.
  • Vestcor Inc left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Vestcor Inc's portfolio in Q2 2026, its #727 holding.
  • Vestcor Inc first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Vestcor Inc's West Pharmaceutical position peaked at $29.4M in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.